Skip to main content
. 2020 Oct 14;15(10):e0240517. doi: 10.1371/journal.pone.0240517

Fig 4. siRNA-mediated knockdown of PRKAA1 (AMPK).

Fig 4

COX10-deficient patient fibroblasts were transfected with AMPK-specific siRNA (siAMPK) or control siRNA (siCNT). Following transfection, cells were (A) evaluated for protein expression by western blotting, or (B) treated with PT1 or DMSO (vehicle) for an additional 6 days and then evaluated for viability by calcein-AM fluorescence assay and (C) morphology by phase contrast microscopy.